BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12580565)

  • 1. Genetic disorders and renal cell carcinoma.
    Maranchie JK; Linehan WM
    Urol Clin North Am; 2003 Feb; 30(1):133-41. PubMed ID: 12580565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of familial renal cell carcinoma syndromes.
    Cohen D; Zhou M
    Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
    Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M
    Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial non-syndromic clear cell renal cell carcinoma.
    Woodward ER
    Curr Mol Med; 2004 Dec; 4(8):843-8. PubMed ID: 15579031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic basis of cancer of the kidney.
    Linehan WM; Walther MM; Zbar B
    J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of kidney lesions in von Hippel-Lindau disease.
    Neumann HP; Riegler P; Huber W; Corradini R; Sessa A; Fontana D; Wetterauer U; Janetschek G
    Contrib Nephrol; 2001; (136):193-207. PubMed ID: 11688380
    [No Abstract]   [Full Text] [Related]  

  • 8. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
    Richard S
    Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
    Wiesener MS; Eckardt KU
    Nephrol Dial Transplant; 2002 Mar; 17(3):356-9. PubMed ID: 11865075
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic and clinical aspects of familial renal neoplasms.
    Iliopoulos O; Eng C
    Semin Oncol; 2000 Apr; 27(2):138-49. PubMed ID: 10768593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Hippel-Lindau disease: the role of gene analysis in affected families.
    Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A
    Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
    Petrella BL; Lohi J; Brinckerhoff CE
    Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of renal tumours.
    Fleming S
    Cancer Metastasis Rev; 1997 Jun; 16(1-2):127-40. PubMed ID: 9156283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited renal cancer.
    Turner KJ
    BJU Int; 2000 Jul; 86(2):155-64;quiz i. PubMed ID: 10886102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.